Medite Cancer Diagnostics, Inc.

Medical device company · Chicago, Illinois, United States

Medite Cancer Diagnostics, Inc. is a medical device company headquartered in Chicago, Illinois, United States. It has reported private securities offerings to the US SEC, most recently $870,000 sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Medite Cancer Diagnostics at a glance

Typemedical device company
HeadquartersChicago, Illinois, United States
SEC industrySurgical & Medical Instruments & Apparatus
SEC CIK75439

What does Medite Cancer Diagnostics do?

Private fundraising reported to the SEC

11 Form D notices; the most recent reported $870,000 sold (2018).

Frequently asked questions about Medite Cancer Diagnostics

Where is Medite Cancer Diagnostics headquartered?

Medite Cancer Diagnostics, Inc. is headquartered in Chicago, Illinois, United States.

What does Medite Cancer Diagnostics do?

Medite Cancer Diagnostics, Inc. is a medical device company. Its SEC industry classification is Surgical & Medical Instruments & Apparatus.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences